OUR VISION
MAXIMIZING PATIENT'S BENEFITS
RX.nxt develops innovative drugs by improving physico-chemical specifications and generating patient’s benefit. We solve the problem of solubility and bioavailability of most drugs by unique cutting edge technology.
Technology driven innovation for better health.
WHAT IS RX.NXT?
RX.nxt is an R&D company that develops smart re-formulated drugs with medical added value to increase value creation of successfully established drugs.
WHAT WE DO
WHAT IS RX.NXT?
RX.nxt is an R&D company that develops smart re-formulated drugs with medical added value to increase value creation of successfully established drugs.
THE PROBLEM
More than 60% of all drugs available are poorly soluble in water what makes them less bioavailable. The lack of solubility leads to
- transient API (active pharmaceutical ingredient) level in blood plasma – intra- and interpatient variability
- food effects – bioavailability is highly dependent on ingestion
- loss of therapeutic efficacy
These challenges require higher drug dosage what leads to exacerbation of side effects and may cause dose dumping phenomenon. Using smaller API particles lead to increasing solubility, solution rate and bioavailability – size matters.
OUR SOLUTION
By using cutting edge nanotechnologies RX.nxt solves the problem of more than 60% of existing drugs – the lack of solubility and bioavailability.
RX.nxt re-formulated drugs generate added value by
- improving drug solubility and rate of solution
- increasing bioavailability
- elimination of food effect
- reduction of drug dosage without loss of efficacy
- improving side effect profile

THE TECHNOLOGY
RX.nxt increases solubility and rate of solution by using bottom-up nanotechnology.
- All pharmaceutical forms possible (e.g. oral, parenteral)
- No scale up from laboratory necessary – it all can be done with the same unit
- no capacity limitation
- small and mobile unit can be integrated in GMP production facilities
- broad range of APIs suitable with the technology
- no toxic solvents necessary – clean meds
- lower cost of goods
Less limitations, more efficiency.
RX.nxt and our international network
RX.nxt operates within an efficient professional network of all relevant suppliers like API suppliers, CROs, CMDOs and GMP service providers in all phases of preclinical and clinical development up do FDA and EMA approval.